Literature DB >> 21706005

Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b.

Riccardo L Rossi1, Grazisa Rossetti, Lynn Wenandy, Serena Curti, Anna Ripamonti, Raoul J P Bonnal, Roberto Sciarretta Birolo, Monica Moro, Maria C Crosti, Paola Gruarin, Stefano Maglie, Francesco Marabita, Debora Mascheroni, Valeria Parente, Mario Comelli, Emilio Trabucchi, Raffaele De Francesco, Jens Geginat, Sergio Abrignani, Massimiliano Pagani.   

Abstract

MicroRNAs are small noncoding RNAs that regulate gene expression post-transcriptionally. Here we applied microRNA profiling to 17 human lymphocyte subsets to identify microRNA signatures that were distinct among various subsets and different from those of mouse lymphocytes. One of the signature microRNAs of naive CD4+ T cells, miR-125b, regulated the expression of genes encoding molecules involved in T cell differentiation, including IFNG, IL2RB, IL10RA and PRDM1. The expression of synthetic miR-125b and lentiviral vectors encoding the precursor to miR-125b in naive lymphocytes inhibited differentiation to effector cells. Our data provide an 'atlas' of microRNA expression in human lymphocytes, define subset-specific signatures and their target genes and indicate that the naive state of T cells is enforced by microRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21706005     DOI: 10.1038/ni.2057

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  40 in total

1.  Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage.

Authors:  Sergei B Koralov; Stefan A Muljo; Gunther R Galler; Azra Krek; Tirtha Chakraborty; Chryssa Kanellopoulou; Kari Jensen; Bradley S Cobb; Matthias Merkenschlager; Nikolaus Rajewsky; Klaus Rajewsky
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

Review 2.  Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.

Authors:  Alison H Banham
Journal:  Trends Immunol       Date:  2006-10-12       Impact factor: 16.687

3.  MicroRNA miR-125b causes leukemia.

Authors:  Marina Bousquet; Marian H Harris; Beiyan Zhou; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-30       Impact factor: 11.205

4.  Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.

Authors:  Raquel Malumbres; Kristopher A Sarosiek; Elena Cubedo; Jose W Ruiz; Xiaoyu Jiang; Randy D Gascoyne; Robert Tibshirani; Izidore S Lossos
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

5.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

6.  Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.

Authors:  Eva V Acosta-Rodriguez; Laura Rivino; Jens Geginat; David Jarrossay; Marco Gattorno; Antonio Lanzavecchia; Federica Sallusto; Giorgio Napolitani
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

7.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

8.  Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

Authors:  Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

9.  Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.

Authors:  N Gefen; V Binder; M Zaliova; Y Linka; M Morrow; A Novosel; L Edry; L Hertzberg; N Shomron; O Williams; J Trka; A Borkhardt; S Izraeli
Journal:  Leukemia       Date:  2009-11-05       Impact factor: 11.528

10.  Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells.

Authors:  Laura Rivino; Mara Messi; David Jarrossay; Antonio Lanzavecchia; Federica Sallusto; Jens Geginat
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  129 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

Authors:  Clayton A White; Egest J Pone; Tonika Lam; Connie Tat; Ken L Hayama; Guideng Li; Hong Zan; Paolo Casali
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 3.  MicroRNAs are shaping the hematopoietic landscape.

Authors:  Ute Bissels; Andreas Bosio; Wolfgang Wagner
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

Review 4.  Highlights of the advances in basic immunology in 2011.

Authors:  Juan Liu; Shuxun Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

5.  Circulating hepatitis B surface antigen particles carry hepatocellular microRNAs.

Authors:  Luisa Novellino; Riccardo L Rossi; Ferruccio Bonino; Daniela Cavallone; Sergio Abrignani; Massimiliano Pagani; Maurizia R Brunetto
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Evidence for miRNA expression differences of HIV-1-positive, treatment-naive patients and elite suppressors: a re-analysis.

Authors:  Kenneth W Witwer; Janice E Clements
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

7.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

8.  Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury.

Authors:  Roshni Rao; Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

9.  MicroRNA-146a controls functional plasticity in γδ T cells by targeting NOD1.

Authors:  Nina Schmolka; Pedro H Papotto; Paula Vargas Romero; Tiago Amado; Francisco J Enguita; Ana Amorim; Ana F Rodrigues; Katrina E Gordon; Ana S Coroadinha; Mark Boldin; Karine Serre; Amy H Buck; Anita Q Gomes; Bruno Silva-Santos
Journal:  Sci Immunol       Date:  2018-05-04

10.  Cholera toxin directly enhances IL-17A production from human CD4+ T cells.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.